CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bloomage BioTechnology Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bloomage BioTechnology Corporation
23/F, Tower D, CITC
6A Jianguomenwai Avenue, Chaoyang Distri
Phone: +86 1085670099p:+86 1085670099 Beijing, China Ticker: 963963
This company is no longer actively traded on any major stock exchange.
Business Summary
Bloomage BioTechnology Corporation Limited is a Hong Kong-based investment holding company principally engaged in the research and development, production and sales of hyaluronic acid sodium (HA) products. The main products of the Company include HA raw materials and HA end products. HA raw materials include Hyatrue Pharmaceutical Grade Sodium Hyaluronate, HAPLEX Food Grade Sodium Hyaluronate and Freda Cosmetic Grade Sodium Hyaluronate. HA end products include the injectable hyaluronan soft tissue filling gel, BioHyalux, and the medical use sodium hyaluronate gel, HYMOIS. Its products are applied in industries of medicine, plastic surgery, cosmetics and food supplements, among others. The Company operates businesses in China, Asia and America.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/201712/31/2016Yes----

Industries
SIC Code Description
2869 Industrial organic chemicals, not elsewhere classified
2833 Medicinal chemicals and botanical products
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board YanZhao 48
Chief Executive Officer, Executive Director XuekunJin 50 12/20/2013 6/18/2012
Chief Financial Officer, Executive Director AnminGong 50 8/26/2016 1/1/2014
10 additional Officers and Directors records available in full report.

Business Names
Business Name
963
Bloomage BioTechnology Corporation Ltd

General Information
Number of Employees: 771 (As of 6/30/2017)
Outstanding Shares: 366,285,834 (As of 9/30/2017)
Stock Exchange: HKG


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023